Form 4: AdaptHealth Director Theodore B. Lundberg Reports Transaction
SEC Form 4 Filing
Theodore B. Lundberg, a director of AdaptHealth Corp., reported the acquisition and disposal of common stock on June 24, 2024.
Summary
- On June 24, 2024, Theodore B. Lundberg, a director of AdaptHealth Corp., reported a transaction involving the company's common stock.
- Lundberg acquired 17,523 shares of common stock at $0.
- Lundberg disposed of 830,546 shares of common stock.
- Following the reported transactions, Lundberg beneficially owns 830,546 shares of AdaptHealth Corp.
- The reporting was filed as a Form 4, indicating a change in beneficial ownership.
- Jonathan B. Bush is acting as attorney-in-fact for Theodore B. Lundberg.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the director's stock transactions as an indicator of confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| April 16, 2024 | Date of Power of Attorney execution. |
| June 24, 2024 | Date of the reported stock transaction. |
| June 26, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.